| Literature DB >> 26544671 |
Helena Hildenwall1,2, Ben Amos2, George Mtove2,3, Florida Muro4, Kerstin Cederlund5,6, Hugh Reyburn7.
Abstract
OBJECTIVE: In sub-Saharan Africa, the use of malaria rapid diagnostic tests (mRDT) has raised awareness of alternative fever causes in children but few studies have included adults. To address this gap, we conducted a study of mRDT-negative fever aetiologies among children and adults in Tanzania.Entities:
Keywords: AIEPI; IMAI; Integrated Management of Adolescent and Adult Illness; Integrated Management of Childhood Illness; PCIME; Tanzania; Tanzanie; aetiology; etiología; fever; fiebre; fièvre; malaria; manejo integrado enfermedades en adultos; no-malaria; non paludique; non-malaria; étiologie
Year: 2015 PMID: 26544671 PMCID: PMC4738434 DOI: 10.1111/tmi.12635
Source DB: PubMed Journal: Trop Med Int Health ISSN: 1360-2276 Impact factor: 2.622
Basic characteristic of enrolled patients per age group
| 3–59 months ( | 5–12 years ( | 13–<50 years ( | |
|---|---|---|---|
| Females, | 195 (45.6) | 52 (51.0) | 370 (74.3) |
| Temp >37.5, | 196 (45.8) | 19 (18.6) | 51 (10.2) |
| Days with fever, Mean (median) | 3.3 (3) | 3.5 (3) | 5.8 (4) |
| Haemoglobin, Mean (median) | 10.9 (11.0) | 12.7 (13.0) | 13.4 (13.7) |
| Reportedly HIV positive, | Nil | 1 (1.0) | 19 (3.8) |
| Admitted | 27 (6.3%) | 1 (1.0) | 6 (1.2) |
Admitted during the study period (d0–d13).
Clinical features presentation at enrolment by age group
| 3–59 months | 5–12 years | 13–<50 years | |
|---|---|---|---|
| Cough/difficult breathing | 281 (65.7, 61.1–70.2) | 58 (56.9, 47.2–66.5) | 101 (20.3, 16.7–23.8) |
| Coryza/runny nose | 91 (21.3, 17.3–25.1) | 10 (9.8, 4.0–15.6) | 30 (6.0, 3.9–8.1) |
| Rapid breathing for age | 68 (15.9, 12.4–19.4) | 7 (6.9, 1.9–11.7) | 297 (59.6, 55.3–64.0) |
| Diarrhoea or vomiting | 117 (27.3, 23.1–31.6) | 16 (15.7, 8.6–22.8) | 39 (7.8, 5.5–10.2) |
| Fever without other symptoms | 36 (8.4, 5.8–11.0) | 14 (13.7.0–20.4) | 132 (26.5, 22.6–30.4) |
| IMCI/IMAI non‐severe pneumonia | 57 (10.5, 8.8–14.6) | 1 (0.9, −0.9–2.9) | 24 (4.8, 2.9–6.7) |
| IMCI/IMAI severe pneumonia | 15 (3.5, 1.8–5.3) | 15 (14.7, 7.8–21.6) | 19 (3.8, 2.1–5.5) |
Increased respiratory as defined by IMCI/IMAI algorithms per age group, 1–12 months > 50 breaths/minute, 1–5 years > 40 breaths/minute, 5–12 years > 30 breaths/minute, above 13 years > 20 breaths/minute.
Results from bacterial cultures from blood, urine and respiratory tract per age group
| 3–59 months, | 5–12 years, | 13–<50 years, | |
|---|---|---|---|
| Blood | |||
| Bacteria | 6 (1.4) | 3 (2.9) | 4 (0.8) |
| Urine | |||
| Bacteria | 24 (5.6) | Nil | 29 (5.8) |
| Respiratory | |||
| Bacteria | 139 (32.5) | 11 (10.8) | 41 (8.2) |
Proportions of upper respiratory tract infections (URTI), non‐severe, and severe pneumonia as defined by the Integrated Management of Childhood Illness (IMCI) and X‐ray findings in children 3–59 months of age
| URTI | IMCI non‐severe pneumonia | IMCI severe pneumonia | |
|---|---|---|---|
|
Total number |
221 | 45 (10.5) | 15 (3.5) |
|
X‐ray unavailable, | – | 22 (48.9) | – |
|
Normal X‐ray, | – | 14 (60.9) | 4 (26.7) |
|
Consolidation on X‐ray, | – | 3 (13.0) | 4 (26.7) |
|
Other pathology | 6 (26.1) | 7 (46.7) |
Other pathology on X‐ray defined as any non‐consolidation abnormality such as interstitial infiltrates.